Does FRAMYCETIN Cause Mobility decreased? 97 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Mobility decreased have been filed in association with FRAMYCETIN. This represents 30.2% of all adverse event reports for FRAMYCETIN.
97
Reports of Mobility decreased with FRAMYCETIN
30.2%
of all FRAMYCETIN reports
97
Deaths
47
Hospitalizations
How Dangerous Is Mobility decreased From FRAMYCETIN?
Of the 97 reports, 97 (100.0%) resulted in death, 47 (48.5%) required hospitalization, and 42 (43.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FRAMYCETIN. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does FRAMYCETIN Cause?
Infusion related reaction (169)
Headache (165)
Pyrexia (156)
Weight decreased (154)
Nausea (151)
Pain (146)
Dyspepsia (129)
Type 2 diabetes mellitus (124)
Vomiting (120)
Hypertension (117)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which FRAMYCETIN Alternatives Have Lower Mobility decreased Risk?
FRAMYCETIN vs FREMANEZUMAB
FRAMYCETIN vs FREMANEZUMAB-VFRM
FRAMYCETIN vs FROVATRIPTAN
FRAMYCETIN vs FRUCTOSE
FRAMYCETIN vs FRUQUINTINIB